These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Merosin-deficient congenital muscular dystrophy type 1A. Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331 [TBL] [Abstract][Full Text] [Related]
7. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Mercuri E; Pennock J; Goodwin F; Sewry C; Cowan F; Dubowitz L; Dubowitz V; Muntoni F Neuromuscul Disord; 1996 Dec; 6(6):425-9. PubMed ID: 9027850 [TBL] [Abstract][Full Text] [Related]
8. [Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis]. Fardeau M; Tomé FM; Helbling-Leclerc A; Evangelista T; Ottolini A; Chevallay M; Barois A; Estournet B; Harpey JP; Fauré S; Guicheney P; Hillaire D Rev Neurol (Paris); 1996 Jan; 152(1):11-9. PubMed ID: 8729391 [TBL] [Abstract][Full Text] [Related]
9. Visual function in children with merosin-deficient and merosin-positive congenital muscular dystrophy. Mercuri E; Anker S; Philpot J; Sewry C; Dubowitz V; Muntoni F Pediatr Neurol; 1998 May; 18(5):399-401. PubMed ID: 9650678 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations. Vainzof M; Marie SK; Reed UC; Schwartzman JS; Pavanello RC; Passos-Bueno MR; Zatz M Neuropediatrics; 1995 Dec; 26(6):293-7. PubMed ID: 8719743 [TBL] [Abstract][Full Text] [Related]
11. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms]. Nonaka I Nihon Rinsho; 1997 Dec; 55(12):3176-80. PubMed ID: 9436431 [TBL] [Abstract][Full Text] [Related]
15. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. O'Brien DP; Johnson GC; Liu LA; Guo LT; Engvall E; Powell HC; Shelton GD J Neurol Sci; 2001 Aug; 189(1-2):37-43. PubMed ID: 11535231 [TBL] [Abstract][Full Text] [Related]
16. EMG and nerve conduction studies in children with congenital muscular dystrophy. Quijano-Roy S; Renault F; Romero N; Guicheney P; Fardeau M; Estournet B Muscle Nerve; 2004 Feb; 29(2):292-9. PubMed ID: 14755496 [TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy. Talim B; Kale G; Topaloglu H; Akçören Z; Caglar M; Gögüş S; Elkay M Pediatr Dev Pathol; 2000; 3(2):168-76. PubMed ID: 10679036 [TBL] [Abstract][Full Text] [Related]
18. Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Di Muzio A; De Angelis MV; Di Fulvio P; Ratti A; Pizzuti A; Stuppia L; Gambi D; Uncini A Muscle Nerve; 2003 Apr; 27(4):500-6. PubMed ID: 12661054 [TBL] [Abstract][Full Text] [Related]
19. Expression of laminin subunits in congenital muscular dystrophy. Sewry CA; Philpot J; Mahony D; Wilson LA; Muntoni F; Dubowitz V Neuromuscul Disord; 1995 Jul; 5(4):307-16. PubMed ID: 7580244 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of congenital muscular dystrophy and clinical significance of merosin expression]. Xiong H; Yao S; Yuan Y; Chang XZ; Wu Y; Bao XH; Zhang YH; Wu HS; Chen L; Qin J; Wu XR Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):918-23. PubMed ID: 17254461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]